Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
9,954
Stocks News & Analysis
stocks
What we think of the 3 big winners of the ASX 100
Exploring the ASX companies who dominated the market this year
stocks
Ask the analyst: Why have Healius shares struggled so much?
Shares in Australia's second biggest pathology operator have floundered in recent years. Shane Ponraj thinks better days could be ahead.
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,144.30 | 17.40 | 0.21% |
| CAC 40 | 7,876.36 | 85.65 | 1.10% |
| DAX 40 | 22,539.98 | 376.49 | 1.70% |
| Dow JONES (US) | 41,989.96 | 11.80 | -0.03% |
| FTSE 100 | 8,634.80 | 51.99 | 0.61% |
| HKSE | 23,206.84 | 87.26 | 0.38% |
| NASDAQ | 17,449.89 | 150.60 | 0.87% |
| Nikkei 225 | 35,512.57 | 111.91 | -0.31% |
| NZX 50 Index | 12,368.78 | 56.18 | 0.46% |
| S&P 500 | 5,633.07 | 21.22 | 0.38% |
| S&P/ASX 200 | 7,943.10 | 17.90 | 0.23% |
| SSE Composite Index | 3,348.44 | 12.69 | 0.38% |